Axcelis Technologies (NASDAQ:ACLS – Get Free Report) is anticipated to post its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect Axcelis Technologies to announce earnings of $1.11 per share and revenue of $230.08 million for the quarter. Axcelis Technologies has set its Q3 2026 guidance at 1.110-1.110 EPS. Individuals can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The semiconductor company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.17. Axcelis Technologies had a return on equity of 11.69% and a net margin of 10.71%. The firm had revenue of $215.18 million during the quarter, compared to analyst estimates of $205.03 million. During the same quarter last year, the business posted $1.13 earnings per share. The business’s quarterly revenue was up 10.6% compared to the same quarter last year. On average, analysts expect Axcelis Technologies to post $3.39 EPS for the current fiscal year and $4.59 EPS for the next fiscal year.
Axcelis Technologies Trading Down 4.9%
Shares of ACLS stock opened at $95.15 on Tuesday. Axcelis Technologies has a 12-month low of $73.60 and a 12-month high of $193.78. The company has a current ratio of 4.90, a quick ratio of 3.21 and a debt-to-equity ratio of 0.04. The stock’s 50-day moving average price is $117.87 and its 200-day moving average price is $122.67. The stock has a market capitalization of $2.94 billion, a price-to-earnings ratio of 29.09, a price-to-earnings-growth ratio of 3.47 and a beta of 1.86.
Wall Street Analysts Forecast Growth
A number of equities analysts recently commented on ACLS shares. Craig Hallum lowered Axcelis Technologies from a “buy” rating to a “hold” rating and set a $140.00 price target for the company. in a research note on Friday, August 7th. Weiss Ratings upgraded Axcelis Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, October 16th. One research analyst has rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $148.67.
Check Out Our Latest Analysis on ACLS
About Axcelis Technologies
Axcelis Technologies, Inc develops and manufactures equipment used in the fabrication of semiconductor devices. The company is best known for its ion implantation systems, which precisely introduce dopant atoms into silicon wafers to control the electrical properties of semiconductor components.
Its product portfolio includes the Purion family of ion implantation systems, designed for applications such as high-current, medium-current and high-energy implantation. Axcelis also provides related aftermarket products and services, including spare parts, equipment upgrades, process support and customer training.
Headquartered in Beverly, Massachusetts, Axcelis serves semiconductor manufacturers and other customers in major chip-production regions worldwide.
Featured Stories
- Five stocks we like better than Axcelis Technologies
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
